Skip to main content

View full-text article in PMC

. 2021 Apr 25;246(18):1981–1989. doi: 10.1177/15353702211009138

Table 3.

Effects of HRW addition on serum lipid and lipoprotein levels in each individual patient with UA.

	TC				LDL-C				apoB
	Control group		HRW group		Control group		HRW group		Control group		HRW group
Patient number	Before treatment (mM)	After treatment (mM)	Before treatment (mM)	After treatment (mM)	Before treatment (mM)	After treatment (mM)	Before treatment (mM)	After treatment (mM)	Before treatment (g/L)	After treatment (g/L)	Before treatment (g/L)	After treatment (g/L)
1	5.99^a	4.46	6.41^a	4.51	4.38^a	2.19	3.80^a	2.51	1.17	0.99	1.40^a	0.84
2	5.64^a	4.19	6.09^a	3.62	2.22	2.58	3.89^a	1.92	0.70	0.88	1.26^a	0.65
3	5.37	5.08	5.25	5.07	3.87	3.70	3.14	2.83	1.18^a	0.73	1.09	0.94
4	5.06	4.60	4.82	4.43	2.95	2.50	2.68	2.34	0.97	0.87	0.93	0.86
5	4.90	5.14	4.73^a	3.02	2.48^a	1.74	2.81^a	1.49	0.85	0.69	1.05^a	0.61
6	4.73^a	3.60	4.61	4.29	2.57^a	1.89	2.46	2.37	1.04^a	0.75	0.84	0.86
7	4.62	4.35	4.35	5.95	2.42	2.48	2.48	3.18	0.96	0.88	0.99	1.04
8	4.61	3.76	4.25^a	3.10	2.61	2.54	2.42^a	1.39	0.92	0.88	0.79^a	0.55
9	4.40	4.68	4.21	4.25	2.15	1.80	1.95	2.18	0.73	0.63	0.73	0.85
10	4.39	4.45	4.17	4.01	2.94	2.62	2.51	2.42	1.07	0.93	0.87	1.05
11	4.38	4.33	4.04^a	2.32	2.86	3.06	2.31^a	0.98	0.98	1.04	0.73^a	0.46
12	4.04	3.31	4.03	4.07	2.31	1.91	1.96	1.82	0.76	0.65	0.75	0.74
13	4.04	3.77	4.00^a	2.96	2.91	3.10	2.14^a	1.29	0.98	1.07	0.70^a	0.51
14	3.89	3.46	3.90^a	3.04	1.80	1.57	1.73^a	0.95	0.66	0.60	0.60^a	0.37
15	3.81	3.07	3.87	4.45	2.02^a	1.49	2.00	3.36	0.80^a	0.62	0.74	0.73
16	3.67	3.02	3.64	3.34	1.65	1.48	1.86	1.75	0.64	0.59	0.72	0.67
17	3.48	3.87	3.26	2.68	1.47	1.82	1.46^a	1.13	0.58	0.66	0.60^a	0.45
18	3.32	3.43	3.11	5.29	1.66	1.46	1.46	3.09	0.66	0.59	0.60	0.96
19	3.05	4.54	2.76	4.54	1.19	2.05	1.50	2.79	0.81	0.71	0.60	0.92
20	2.91	3.87	2.74	2.49	1.73	2.19	1.31	1.59	0.65	0.73	0.58	0.56
Mean	4.32	4.05	4.21	3.87	2.41	2.21	2.29	2.07	0.86	0.77	0.83	0.73
SD	0.83	0.63	0.95	0.99	0.79	0.61	0.72	0.75	0.18	0.16	0.23	0.21
Effectiverate	15%		35%		20%		40%		15%		40%

^aPatients whose lipid or lipoprotein level was reduced above 20% after treatment for three months compared with the baseline data before treatment. The effective rate was calculated by the marked patients’ number to total patients’ number.

HRW: hydrogen-rich water, UA: unstable angina, TC: total cholesterol, LDL-C: low-density lipoprotein-cholesterol, apoB: apolipoprotein B.